About Us
Ilios Santé GmbH is a company founded in 2019, operating in the pharmaceutical wholesale and manufacturing sector. In addition to permits under §52a AMG, §13 AMG, and §3 BtmG, we are certified according to GMP and GDP. We have the authorization to import and trade in pharmaceuticals and controlled substances.
Our team consists of industry experts with various core competencies who have been dedicated to the medical cannabis sector for several years.
About Us
Ilios Santé GmbH is a pharmaceutical wholesale and manufacturing company founded in 2019, certified according to Good Distribution Practice (GDP) guidelines. We have permission for the import and trade of pharmaceuticals.
Our team consists of industry experts with various core competencies who have been dedicated to the medical cannabis sector for several years.
Our Mission
Gemeinsam haben wir uns zum Ziel gesetzt, den medizinischen Cannabis Markt durch Produktinnovationen voranzutreiben und nachhaltig zu verbessern. Wir bedienen bereits jetzt ein breites Segment des aktuellen Cannabismarktes und planen diesen im Laufe der Zeit weiter zu vergrößern. Durch unsere Marktexpertise und hoch qualifizierte Partner in den Bereichen Anbau und Verarbeitung können wir eine zuverlässige Belieferung unserer Zielgruppen versichern.
The exploration of various medical cannabis strains and their active compounds is considered an essential component of our business strategy. This allows us to utilize different compositions of active ingredients for various medical cannabis therapies and adapt our product range accordingly.
Our Mission
Together, we are committed to advancing and sustainably improving the medical cannabis market through product innovations. We already serve a wide segment of the current cannabis market and plan to expand it further over time. With our market expertise and highly qualified partners in cultivation and processing, we can ensure reliable supply to our target audiences.
The exploration of various medical cannabis strains and their active compounds is considered an essential component of our business strategy. This allows us to utilize different compositions of active ingredients for various medical cannabis therapies and adapt our product range accordingly.
Distribution Network
With its headquarters in Frankfurt am Main, Ilios Santé GmbH aims to establish an international distribution network, starting with Germany as the world's largest market.
Through carefully selected EU-GMP (Good Manufacturing Practice for Medicinal Products) certified partners in cultivation, production, and logistics, we exclusively offer high-quality products to our customers. The secure medical care of patients forms the focal point of our strategy development.
DISTRIBUTIONS-NETZWERK
With its headquarters in Frankfurt am Main, Ilios Santé GmbH aims to establish an international distribution network, starting with Germany as the world's largest market.
Through carefully selected EU-GMP (Good Manufacturing Practice for Medicinal Products) certified partners in cultivation, production, and logistics, we exclusively offer high-quality products to our customers. The secure medical care of patients forms the focal point of our strategy development.
Education
and Awareness Efforts
In addition to distribution, Ilios Santé GmbH places a strong emphasis on educating physicians, pharmacists, and other industry-specific personnel about the mechanisms and availability of cannabinoid-containing medical products.
The goal is to demonstrate the therapeutic benefits of medical cannabis as alternative medicine and break the stigma surrounding the industry.
AUFKLÄRUNGSARBEIT
In addition to distribution, Ilios Santé GmbH places a strong emphasis on educating physicians, pharmacists, and other industry-specific personnel about the mechanisms and availability of cannabinoid-containing medical products.
The goal is to demonstrate the therapeutic benefits of medical cannabis as alternative medicine and break the stigma surrounding the industry.
